Cell surface physiology and outer cell envelope impermeability for hydrophobic substances in Burkholderia multivorans

Cell Envelope Structure and Functions in Gram-negative Bacteria

Editorial: Archaeal Cell Envelope and Surface Structures

Archaea and Bacteria have complex cell envelopes that play important roles in several vital cellular processes, including serving as a barrier that protects the cytoplasm from the environment. Along with associated proteinaceous structures, cell envelopes also ensure cell stability, promote motility, mediate adherence to biotic and abiotic surfaces, and facilitate communication with the extrace...

Mucoid morphotype variation of Burkholderia multivorans

Mucoid morphotype variation of Burkholderia multivorans during chronic cystic fibrosis 1 lung infection is correlated with changes in metabolism, motility, biofilm formation and 2 virulence 3 4 Running title: Phenotype variation in B. multivorans clinical isolates 5 6 Content category: Microbial Pathogenicity 7 8 Inês N. Silva, Ana S. Ferreira, Jörg D. Becker, James E. A. Zlosnik, David P. Spee...

Evidence of transmission of Burkholderia cepacia, Burkholderia multivorans and Burkholderia dolosa among persons with cystic fibrosis.

Previous studies have identified specific Burkholderia cepacia complex strains that are common to multiple persons with cystic fibrosis (CF). Such so-called epidemic strains have an apparent enhanced capacity for inter-patient spread and reside primarily in Burkholderia cenocepacia (formerly B. cepacia complex genomovar III). We sought to identify strains from B. cepacia complex species other t...

Burkholderia cenocepacia and Burkholderia multivorans: influence on survival in cystic fibrosis.

INTRODUCTION Burkholderia cepacia infection has been associated with a poor prognosis for patients with cystic fibrosis (CF). It is now recognised that organisms classified as B cepacia comprise a number of distinct genomic species each known as a genomovar of the B cepacia complex (BCC). The outcome of infection for CF patients with individual genomovars is unknown. The clinical outcome of inf...